An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis: Focus on Tumour Necrosis Factor- Antagonists

Author： Nick J. Bansback Dean A. Regier

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.4, 2005-01, pp. : 473-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite

Tumour necrosis factor blockade in rheumatoid arthritis

By Breedveld Ferdinand C

Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. : 107-109

Royal College Of Physicians

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Antagonists in the Management of Rheumatoid Arthritis in the Elderly: A Review of Their Efficacy and Safety

By Radovits Beáta J. Kievit Wietske Laan Roland F.J.M.

Drugs & Aging, Vol. 26, Iss. 8, 2009-08 ,pp. : 647-664

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor antagonists

By Chantry D.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Tumour necrosis factor- blockade: a new era for effective management of rheumatoid arthritis

By Hamilton K. St. Clair E.W.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1041-1052

Informa Healthcare

Access to resources Recommend Favorite